“When faced with a major medical event such as surgery, cancer or childbirth, patients are often overwhelmed by the health care system and worst of all, financial stress and uncertainty of medical bills. Carrum Health gives patients peace of mind by providing the most appropriate and highest quality care for zero or minimal out-of-pocket costs,” said Brent Nicholson, Co-Founder and Chief Partner Officer of Carrum Health. “Our partnership with Accolade further validates that there is a better way to pay for and deliver healthcare, especially now as employers seek to reduce healthcare costs while delivering improved outcomes and experiences for their employees.”
Carrum Health is the only COE provider to offer a patient-centric app to guide members through their entire COE experience and is also launching an industry first bundled cancer care for employers, in partnership with leading national oncology institutions such as Memorial Sloan Kettering and City of Hope. The platform supports members in need of musculoskeletal, bariatric, oncology, cardiac and maternity care through a value-based bundled payment solution.
Monod Bio, a life sciences company developing personalized diagnostic biosensors, has raised a $25 million seed round. Matrix Capital led the round with participation from Global Health Investment Corp., Cercano Management, The Washington Research Foundation, Boom Capital Ventures, Sahsen Ventures and Pack Ventures.
“We can now design custom biosensors that have specific functions, and this seed funding allows us to illuminate specific molecules like viruses or biomarkers and start building prototypes that can then be turned into real-world diagnostics,” said Daniel -Adriano Silva, Monod Bio CEO and co-founder, in the press release.
“We know that these new biosensors can easily detect viral proteins or antibodies in simulated nasal fluid or donated serum. Our next goal is to ensure that they can be used reliably in a diagnostic environment. Monod Bio’s work illustrates the power of de novo protein design to create molecular devices from scratch with novel and useful functions,” said David Baker, Ph.D., the Henrietta and Aubrey Davis Professor of Biochemistry at the University of Washington School of Medicine and co-founder of Monod Bio, according to the release.
Evri Hello, a health technology company focused on employer health insurance, has expanded into Austin, Houston and San Antonio from its base in Dallas-Fort Worth. The startup, which launched earlier this year, has developed automation software tools that seek to reduce healthcare costs for businesses.
“Expanding our services outside of DFW will help thousands more people access great benefits without having to pay exorbitant prices,” said Chris Gay, CEO of Evry Health, in a press release. “Our team is working hard to provide an innovative group health insurance plan that is affordable for residents of Austin, San Antonio and Houston.”
Trulaone of the leading providers of pharmacy purchasing software in the healthcare industry, has been acquired by SpendMenda company that develops solutions to optimize the health care spending cycle.
Curtis McEntire, CEO of Trulla, founded the business in 2018. McEntire is a former executive in the pharmacy supply chain and supply chain at Intermountain Healthcare.
SpendMend’s acquisition of Trulla is being done in partnership with Morgan Stanley Capital Partners as part of a strategic initiative to expand the value of the SpendMend Pharmacy division, according to the press release.
To read more, Press here.
picture: akindo, Getty Images